INSPECS Group plc Stock
Stocks
SPEC
GB00BK6JPP03
Medical Equipment, Supplies & Distribution
OTC Markets Traded|
Market Closed -
London S.E.
11:35:17 2026-09-21 EDT
|
5-day change | 1st Jan Change | ||
| 93.50 GBX | -2.60% |
|
-2.60% | +30.77% |
| 09-10 | EARNINGS AND TRADING: Physiomics celebrates new contract wins | AN |
| 09-10 | INSPECS Group plc Reports Earnings Results for the Half Year Ended June 30, 2026 | CI |
| Market Cap | 136M 119M 112M 102M 192M 13.08B 192M 1.34B 517M 6.66B 513M 501M 21.48B | P/E 2026 * |
-
| P/E 2027 * | - |
|---|---|---|---|---|---|
| Enterprise Value | 92.42M 80.62M 75.88M 69.13M 130M 8.85B 130M 909M 350M 4.51B 347M 339M 14.54B | EV / Sales 2026 * |
0.35x | EV / Sales 2027 * | 0.33x |
| Free-Float |
10.73% | Yield 2026 * |
-
| Yield 2027 * | - |
London S.E.GBX
| Markets | Quality | ||
|---|---|---|---|
London S.E.
| SPEC | Delayed | |
Deutsche Boerse AG
| 4GV | Delayed |
| 03-04 | Form 8.3 - Inspecs Group Plc | AQ |
| 02-11 | Form 8.3 - Inspecs Group Plc | AQ |
| 02-09 | Form 8.3 - [INSPECS GROUP PLC - 06 02 2026] - (CGAML) | AQ |
| 01-27 | Form 8.3 - Inspecs Group Plc | AQ |
| 01-07 | Form 8.3 - Inspecs Group Plc | AQ |
| 1 day | -2.60% | ||
| 1 week | -2.60% | ||
| Current month | -2.60% | ||
| 1 month | -2.60% | ||
| 3 months | -6.97% | ||
| 6 months | +12.65% | ||
| Current year | +30.77% |
| 1 week | 90 |  | 100 |
| 1 month | 90 | | 100 |
| Current year | 60 | | 105 |
| 1 year | 39 | | 105 |
| 3 years | 37 | | 105 |
| 5 years | 37 | | 420 |
| 10 years | 37 | | 420 |
| Manager | Title | Age | Since |
|---|---|---|---|
Richard Peck
CEO | Chief Executive Officer | 62 | 2022-11-30 |
Christopher Kay
DFI | Director of Finance/CFO | 63 | - |
Angela Eman
CMP | Compliance Officer | - | - |
| Director | Title | Age | Since |
|---|---|---|---|
Richard Peck
BRD | Director/Board Member | 62 | 2020-01-09 |
Angela Farrugia
BRD | Director/Board Member | 61 | 2020-05-11 |
Luke Johnson
BRD | Director/Board Member | 64 | 2026-05-18 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | Importance |
|---|---|---|---|---|---|---|
| 6/4/25 | Free | Chief Executive Officer | 250,000 | 0.2459% | ||
| 6/4/25 | Free | Chief Executive Officer | 150,000 | 0.1475% | ||
| 11/8/22 | Buy | Chief Executive Officer | 833,333 | 0.8196% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -2.60% | -2.60% | +128.05% | +9.36% | 140M | |
| +1.62% | -3.52% | -48.39% | -19.44% | 73.26B | |
| -0.26% | -0.85% | -12.66% | -26.18% | 31.5B | |
| -3.30% | +0.31% | - | - | 12.81B | |
| -2.12% | +0.39% | -20.61% | -35.69% | 10.51B | |
| +8.23% | +3.24% | -1.08% | +634.45% | 2.5B | |
| +1.59% | +2.51% | -40.52% | -60.60% | 1.34B | |
| -3.85% | +1.60% | - | - | 973M | |
| +2.78% | +10.75% | +27.99% | +11.20% | 956M | |
| +2.15% | +8.52% | -34.21% | -19.16% | 892M | |
| Average | +0.42% | +1.73% | -0.18% | +61.74% | 13.49B | |
| Weighted average by Cap. | +0.51% | -2.26% | -34.71% | -9.28% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 267M 233M 219M 200M 375M 25.6B 375M 2.63B 1.01B 13.04B 1B 981M 42.05B | 277M 241M 227M 207M 388M 26.51B 389M 2.72B 1.05B 13.51B 1.04B 1.02B 43.55B |
| Net income | - | - |
| Net Debt | -44.08M -38.45M -36.19M -32.97M -61.84M -4.22B -61.91M -434M -167M -2.15B -166M -162M -6.94B | -45.44M -39.64M -37.31M -33.99M -63.76M -4.35B -63.83M -447M -172M -2.22B -171M -167M -7.15B |
Employees
1,656
| Date | Price | Change | Volume |
|---|---|---|---|
| 26-09-21 | GBX 93.50 | -2.60% | 25,652 |
| 26-09-18 | GBX 96.00 | 0.00% | 82 |
| 26-09-17 | GBX 96.00 | 0.00% | 0 |
| 26-09-16 | GBX 96.00 | 0.00% | 1,877 |
| 26-09-15 | GBX 96.00 | 0.00% | 14,019 |
Sell
Buy
Mean consensus
OUTPERFORM
Number of Analysts
1
Last Close Price
1.250USD
Average target price
0.8180USD
Spread / Average Target
-34.57%
Annual profits - Rate of surprise
- Stock Market
- Stocks
- SPEC Stock
Select your edition
All financial news and data tailored to specific country editions
